Related Experiment Video
Updated: Jul 3, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018
A model free approach to combining biomarkers
Ruth M Pfeiffer1, Efstathia Bur
1Biostatistics Branch, National Cancer Institute, 6120 Executive Blvd, EPS/8030, Bethesda, MD 20892, USA. pfeiffer@mail.nih.gov
This study introduces a novel composite marker score to improve disease diagnosis by combining multiple biomarkers. This approach enhances diagnostic accuracy without complex modeling, offering a more reliable tool for identifying diseases.
Area of Science:
- Biostatistics
- Medical Diagnostics
- Bioinformatics
Background:
- Single biomarkers often lack sufficient sensitivity and specificity for accurate disease diagnosis.
- Developing reliable diagnostic tools requires methods that can integrate information from multiple sources.
Purpose of the Study:
- To develop a composite marker score by combining multiple biomarkers without assuming predictor distribution models.
- To assess the diagnostic performance of the composite score using the area under the receiver-operator characteristics curve (ROC).
- To derive a statistical test for evaluating the contribution of individual biomarkers.
Main Methods:
- Utilized sufficient dimension reduction techniques to create lower-dimensional representations of original markers.
- Employed linear transformations of markers containing relevant information for outcome prediction.
- Combined linear transformations into a scalar diagnostic score using asymptotic properties and the likelihood ratio statistic.
Main Results:
- The developed composite marker score demonstrates improved diagnostic ability.
- The area under the receiver-operator characteristics curve (ROC) is used to quantify performance.
- An asymptotic chi-squared test was derived to assess individual biomarker significance.
Conclusions:
- The proposed composite marker score offers a robust method for disease diagnosis by integrating multiple biomarkers.
- This approach provides a more sensitive and specific diagnostic tool compared to single biomarkers.
- The method is statistically sound and includes a test for biomarker contribution.
Related Concept Videos
Mechanistic Models: Compartment Models in Individual and Population Analysis
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model Approaches for Pharmacokinetic Data: Physiological Models
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
